IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $168,077 | -14.7% | 4,450 | 0.0% | 0.03% | -15.4% |
Q3 2022 | $197,000 | +19.4% | 4,450 | 0.0% | 0.04% | +18.2% |
Q2 2022 | $165,000 | -86.1% | 4,450 | -77.9% | 0.03% | -69.7% |
Q2 2020 | $1,185,000 | -93.2% | 20,100 | -95.4% | 0.11% | -87.2% |
Q1 2016 | $17,549,000 | +88.9% | 433,300 | +188.9% | 0.85% | +114.4% |
Q4 2015 | $9,290,000 | – | 150,000 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |